Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Vaccination
100%
In Silico
100%
Adjuvant Activity
100%
CXCR4 Antagonist
100%
CCR4
100%
Dendritic Cells
100%
Regulatory T Cells
100%
Immune Response
50%
CCL22
50%
CCL17
50%
Cellular Immune Response
25%
T Cells
25%
Mycobacterium Tuberculosis (M. tb)
25%
Hepatitis B Surface Antigen (HBsAg)
25%
Recombinant
25%
Cell-mediated
25%
Virtual Screening
25%
Humoral Immune Response
25%
Adjuvant Discovery
25%
Molecular Docking
25%
In Vitro Immune Response
25%
In Silico Modeling
25%
Chemokine CCL17
25%
Structure-based Drug Design
25%
Treg
25%
Negatively Regulate
25%
Regulatory T (Treg) Cells
25%
T Cell Proliferation
25%
Antigen Vaccine
25%
MVA85A
25%
Chemokine CCL22
25%
CD25
25%
Modified Vaccinia Virus Ankara
25%
Alum
25%
Chemotactic Agent
25%
Ag85A
25%
Response Model
25%
Th2 Cells
25%
Human CD4 T Cells
25%
Medicine and Dentistry
In Silico
100%
Dendritic Cell
100%
Adjuvant
100%
Chemokine Receptor CCR4 Antagonist
100%
Regulatory T Cell
100%
Immune Response
75%
T Cell
25%
Pathogen
25%
In Vitro
25%
Cellular Immunity
25%
Humoral Immunity
25%
Mycobacterium Tuberculosis
25%
Thymus and Activation Regulated Chemokine
25%
Docking (Molecular)
25%
Virtual Screening
25%
Membrane Antigen
25%
Vaccinia
25%
Chemokine Receptor CCR4
25%
Th2 Cell
25%
Macrophage Derived Chemokine
25%
T-Helper Cell
25%
T Cell Proliferation
25%
Hepatitis B Virus
25%
Immunology and Microbiology
CCR4
100%
Regulatory T Cell
100%
Adjuvant
66%
Dendritic Cell
66%
Immune Response
50%
CCL17
33%
CCL22
33%
Experimental Model
16%
T Cell
16%
Infectious Agent
16%
Adoptive Immunity
16%
Humoral Immunity
16%
CD4
16%
Molecular Docking
16%
Chemokine Receptor CCR4
16%
Mycobacterium Tuberculosis
16%
T-Helper Cell
16%
T Cell Proliferation
16%
Hepatitis B Virus
16%
Modified Vaccinia Ankara
16%
Th2 Cell
16%
Macrophage Derived Chemokine
16%
Membrane Antigen
16%
CD25
16%
Thymus and Activation Regulated Chemokine
16%
In Vitro
16%